Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Enzymit

Explore full profile

Enzymit is building a new transformation layer for molecular manufacturing

Rehovot, IsraelFounded 2020Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Enzymit and the history behind them.

About Enzymit

Enzymit is creating a new transformation layer for manufacturing by combining computational enzyme design, deep learning, and a proprietary high-throughput discovery platform.

Read full description

We develop novel enzymatic pathways and run them in controllable cell-free production systems. This approach merges the selectivity of biology with the precision of chemistry, enabling cleaner and more efficient production.

Our platform has been validated with pharmaceutical-grade hyaluronic acid (HA), produced at kilogram scale with superior consistency and purity compared to fermentation. We are now advancing toward commercial HA supply while expanding the platform to products like heparin and human milk oligosaccharides (HMOs).

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Rehovot, Israel
Employees
27
Open positions
1
Dealroom signal
82.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biochemical, Enzymes, Nutrition, Synthetic Biology, Spinout, Food Innovation, Sustainable Development Goals, Fermentation
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Enzymit.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Sep 2024 $10M $40M Sapir Venture Partners · First Star Venture Capital · Khosla Ventures · Grove Ventures
GRANTOther financing Nov 2022 $500K The Israel Innovation Authority
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Enzymit website traffic

Latest recorded traffic for Enzymit is 1.2K monthly website visits, up 0% over the last three months. Enzymit's team grew 8% over the past year.

Latest monthly visits1.2K 3-month web change0% 1-year team growth+8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • The Israel Innovation Authority
  • First Star Venture Capital

Series A3 investors entered at this stage

Other known investors4 additional known investors

  • Weizmann Institute of Science
  • DIVEdigital
  • StartLife
  • Technology Pioneers | World Economic Forum
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇱 Israel90.5%
🇺🇸 United States4.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Enzymit on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enzymit’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.